Amgen
Search results
Onyx Pharmaceuticals Inc. has been a biopharmaceutical company headquartered in South San Francisco, California. The company developed and marketed medicines for the treatment of cancer. Onyx was founded in 1992 by Kevin J. Kinsella and Frank McCormick Ph.D., FRS.
Aug 26, 2013 · About Onyx Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways.
Onyx Pharmaceuticals was a biotechnology company that developed and commercialized cancer therapies. It was acquired by Amgen in 2013 and is now part of its South San Francisco headquarters.
Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company develops and commercializes therapies that target the molecular mechanisms that cause cancer.
Onyx Pharmaceuticals is a biopharmaceutical company acquired by Amgen in 2013. It develops Nexavar, a multiple kinase inhibitor for cancer treatment. See its founders, investors, funding, and similar companies.
Aug 25, 2013 · Amgen paid $125 per share in cash for Onyx, a biopharmaceutical company with a multiple myeloma franchise and a pipeline of oncology products. The acquisition enhanced Amgen's oncology portfolio and revenue growth, and was expected to be accretive to adjusted net income in 2015.
Aug 25, 2013 · After starting out with an unsolicited $120-a-share offer for Onyx ($ONXX), the giant biopharma company settled on a final price of $125 a share--all of it to be paid in cash--valuing Onyx at...
